Daily news email for March 21, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Definiens Expands Stereology Capabilities for Quantitative Digital Pathology

Ceva Takes Commercial License for ProBioGen's AGE1.CR Cell Line for Viral Vaccine Production

UCB and Domainex Collaboration Provides Valuable Information on Cancer Drug Target

Medicyte and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies

Annual Report on Celera (Quest) License

BioSpace
FDA Panel Rejects Ariad Pharmaceuticals, Inc., Merck & Co., Inc. Cancer Drug for Sarcoma Patients

CEO: Eli Lilly and Company to Focus on Cancer, Diabetes in China

FDA Clears Expanded Compatibility for Ikaria Inc.'s INOMAX Drug-Delivery Systems

Facebook's Dark Side, Western Illinois University Study

Paladin Labs Inc. Announces Canadian Approval for Oralair(TM)

BioSpace - Breaking News
Halo Therapeutics, LLC Reports Favorable Independent Review of Lead Drug Candidate HT-100

iBio, Inc. Announces Successful Completion of H1N1 Influenza Vaccine Phase 1 Clinical Trial

Entest Biomedical, Inc. Excited With Progress on 10 Dog Pilot Study of "Universal Donor" Stem Cell Treatment for Canine Osteoarthritis

Unilabs SA Announces First-Year Status on CE Marked STRATIFY JCV ELISA Testing

National Cheng Kung University Medical College Signs MOU with Ohio State University on Cancer Research

Biotech News - Business Wire
Freshmedx Study Published in the Journal of Thoracic Oncology, the Official Journal of the International Association for the Study of Lung Cancer

Acucela Inc. to Participate in Upcoming Retinal Physician Symposium in Miami, Florida

Bridge Report on CellSeed Issued: FY12/11 Earnings in Line with Revised Estimates, the Company Calls for Operating Losses on Back of Anticipatory Investments and Despite Sales Growth in FY12/12

Cerus Submits Investigational Device Exemption (IDE) Supplement to FDA for Phase III INTERCEPT Red Blood Cell Study

2012 BIO International Convention to be held Jun 18 - 21, 2012, in Boston MA, US

Biotech News - PR Newswire
Particle Sciences and Pernix Therapeutics Enter into an Agreement to Develop a Pediatric Dermatology Product

The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect

joimax® With new Products at the International Spring Congresses: ISASS in Barcelona and EndoVienna in Vienna

Bioquark Inc., Organ Regeneration and Tissue Repair Company, Retains JSBarkats PLLC for Public Offering and PIPE Financing

Marken Launches Exclusive Shipping System for Specimen Logistics

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Shire Surprisingly Pulls Biologics License Application

Biogen Idec Looks Ahead on MS

Asahi Kasei Expands in Healthcare with $2.2 Billion Zoll Medical Buy

Pfizer Ends $350 Million Insulin Pact

Boston Scientific Connects With Vodafone for Cardiac Monitoring

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
SpineSearch Added to Premier Supplier Diversity Agreement for Physician Staffing

Research and Markets: Overactive Bladder Global Clinical Trials Review, H1, 2012

Research and Markets: Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012

Research and Markets: Malnutrition Global Clinical Trials Review, H1, 2012

Mobile Clinician Practice Improves Efficiency & Security with Online Tech's HIPAA Compliant Cloud

Clinical Trials - PR Newswire
PTV Interview Exclusive: Revolutionary GSK and J&J Participation in New Index Ventures Fund

University of Kentucky Medical Center Discharges State's 1st SynCardia Total Artificial Heart Patient

OptiScan Biomedical Presents Study Results Demonstrating OptiScanner's Excellent Glucose Monitoring Accuracy in Critically Ill ICU Patients

Collaborative Study from the Diabetes Research Institute Federation and The Cure Alliance Shows that Stem Cells Can Replace Powerful Anti-Rejection Drug to Prevent Rejection and Improve Outcome in Transplant Recipients

Going to the Mountains Pack Ibuprofen to Prevent Altitude Sickness

CNN Top Stories
Opinion: When to give kids cell phones

Colombia: Dozens of guerrillas killed

Plea change in Miss. hate crime case

France shootings suspect holed up after cops move in

Venus Williams returns to tennis

Contract Pharma
Tarsa, QS in Supply Pact

Galapagos Delivers Candidate in Janssen Alliance

GE Healthcare Expands Shanghai Fast Trak Training Center

Shimadzu, Sony DADC Extend Collaboration

CTI Appoints Clinical Trial Ops VP

FDA Drugs- What's New
Postmarketing Requirements and Commitments: Reports

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury

FDA News - Business Wire
Additional Scientific Perspective Offered on Pending FDA Decision on BPA

Anulex Technologies, Inc. Resolves FDA Warning Letter

Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote on Investigational Medicine Ridaforolimus for the Treatment of Metastatic Soft-Tissue or Bone Sarcomas

First Australian Patients Enrolled in Gore Global Registry for Endovascular Aortic Treatment

Samenvatting: Covidien meldt FDA 510(k) toestemming voor Nellcor Respiration Rate Software

FDA Press Releases
FDA approves first Boniva generics to treat or prevent osteoporosis

FDA proposes lower risk classification, guidance for certain tuberculosis tests

FDA proposes lower risk classification for certain tuberculosis tests

FDA approves first generic Lexapro to treat depression and anxiety disorder

La FDA aprueba nuevos implantes de seno rellenos de gel de silicona

FDA Vaccines, Blood and Biologics - What's New
Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

FierceBiotech
UPDATED: Cytos revives lead program in $40M financing deal with Amgen, venBio

J&J unit to pay $8.7M to Galapagos for drug candidate

NicOx eyes global status in eye drug game with up to $30.9M buyout of Altacor

Amarin jumps on positive patent news for blockbuster hopeful

NicOx eyes global status in eye drug game with up to $30.9M buyout of Altcor

FierceBiotech IT
IBM gets personal with biomedical analytics

Merck taps Numerate for computerized cardio drug discovery

Medidata lauded on Wall Street; CEO takes shot at rival Oracle

GSK strikes deal to listen in on social media chatter

Medidata lauded on Wall Street, CEO takes shot at rival Oracle

FierceBiotech Research
UPDATED: Frog skin secretions: icky but potent new anti-bacterials

Mayo Clinic concocts skin cancer vaccine using virus, melanoma DNA

Frog skin secretions: icky but potent new anti-bacterials

Latest anti-RAGE compound defeats Alzheimer's symptoms in mice

Ban on animal importation puts U.K. research at risk

FiercePharma
Pharma sales execs: Current model is broken; changes are coming

Teva to jump to NYSE

Targacept management acknowledges layoffs are possible

Pfizer to pay $3.3M to settle Zyvox probe

FDA panel backs GSK's Votrient for soft-tissue sarcoma

FiercePharma Manufacturing
Fire disrupts production at Teva plant in Croatia

Warehouse strike creates drug shortages in Australia

Pfizer, Lilly and Sanofi help authorities break up counterfeiters

Sandoz's role in Canadian drug shortages adds to calls for regulation

FDA says APP ignored consumer complaints for 18 months

FierceVaccines
First U.S. cholera vax ready for PhIII

World has huge unmet vaccine needs

In the clinic, Inovio's HIV vaccine treats as well as prevents

Hep C vaccine heads into further clinical trials

GeoVax steps closer to HIV prevention

Health News - BizJournals.com
Kaleida adding services at Amherst clinic

You can win $20K from Blue Cross and Blue Shield of North Carolina to help combat obesity

Debbie Branson named chairwoman of Parkland Hospital board

UC Davis offers new residency programs for vascular and thoracic surgery

Bruschetta & nanobiotech on tap at networking event

Health News - CNBC
Watson Close to $7 Billion Purchase of Actavis: Report

Exclusive: Watson close to $7 billion Actavis drug deal: sources

Lawmakers: Fake pharmacies price gouging on drugs

Lawmakers probe pharmacy ties to drug shortages

Geithner on Housing

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Lilly CEO Discusses Plans to Double Growth in China

Index Ventures Launches 150M Life Sciences Fund with GSK, J&J

Cytos to Secure up to CHF 37M to Advance Phase II Asthma Immunotherapy

Index Ventures Launches 150M Life Sciences Fund with GSK and J&J

Supreme Court Unanimously Overturns Prometheus Dosage Calibration Method Patent

Marketwire - Pharma and Biotech
Novo Nordisk A/S: Resolutions from the Annual General Meeting of Novo Nordisk A/S

Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID)

ZoomMed signe une autre alliance stratque avec Insurance Data Services, un fournisseur amcain de services dans la sant

ZoomMed Enters Into Another Strategic Alliance With Insurance Data Services, a U.S. Healthcare Service Provider

Miami Cloud Computing Conference in April to Address Flood of Digital Information

MassBio News
Norton High School Named MassBioEd Innovative School of the Year

Vertex Founder Joshua Boger to Receive MassBio's Henri Termeer Innovative Leadership Award

MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

Medical Pharma - PR Newswire
Five Black Women Die Needlessly Per Day From Breast Cancer in the United States

Broadspire® Hosts First Pharmacy Summit

Roka Bioscience Awarded AOAC-RI Certification for Atlas Salmonella Detection Assay

Huntzinger Management Group, Inc., (HMG) Further Invests in Healthcare Industry's "90 Percent"

BETA Healthcare Group's Risk Management Programs Have Improved Patient Safety for Many California Hospitals and Medical Groups

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
Know before you go

Confronting the Gordian knot

Agbiotech 2.0

Tiptoeing around transgenics

Mission Therapeutics

New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

New York Times- Pharmaceuticals
Cheap Drug, Tranexamic Acid, Is Found To Staunch Bleeding

Generic Drugs Prove Resistant to Damage Claims

Drug Lawsuits Hinge on the Detail of a Label

A Drumbeat on Profit Takers

WELL; The Consumer: Pills' Risks Complicate Long Wait For Sleep

OnBioVC
1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

Outsourcing-Pharma
European CMO market will double in just 6 years, says Frost & Sullivan

Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert

An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Pharma News - Business Wire
Annonce dun nouvel investissement collaboratif de 150 millions deuros lors de la conférence BIO-Europe Spring® 2012 qui se tient à Amsterdam

Resumen: BIO-Europe Spring® 2013 se celebrará en Barcelona

Notice of Annual General Meeting in Moberg Derma AB (publ)

Resumen: Anunciada nueva inversión de colaboración de 150 millones de euros en BIO-Europe Spring® 2012 en Ámsterdam

Novel EUR 150 Million Collaborative Investment Announced at BIO-Europe Spring® 2012 in Amsterdam

Pharma News - PharmiWeb
8th Annual World Health Care Congress Set for Amsterdam, Spring 2012

Patient safety group calls for urgent action on unlicensed medicines

EISAI EXPANDS OPERATIONS IN EUROPE, THE MIDDLE EAST AND AFRICA

"Dr. Hotspot," Jeffrey Brenner, MD, to Deliver Keynote Address at the PCPCC Stakeholder Conference April 23

BLOOD VESSEL INFLATOR COULD BE GAME-CHANGER FOR PANCREATIC CANCER TREATMENT

Pharma News - PR Newswire
CVS Caremark to Sponsor PoliticoPro Briefing on Upcoming Supreme Court Hearing on Affordable Care Act

Ronald L. Chez Files Amended Repligen 13D Urging Positive Director Action on Behalf of Shareholders

BHR Pharma's SyNAPSe® Trial Reaches Important Enrollment Milestone on Brain Injury Awareness Day

Cardinal Health Specialty Solutions Submits 1,000th Electronic Common Technical Document (eCTD) to FDA

Altitude Organic New Dispensary Counter-Space Acquisition Program - Zazzz - Signs Premier Location

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Burns Engineering Releases White Paper on Wire Imbalance in 3-wire RTD...

Kentucky's 1st SynCardia Total Artificial Heart Patient Discharged...

Next Breath, LLC Accredited by World Health Organization (WHO)

Matakina Receives Health Canada Approval for Volpara Breast Density...

Design Breakthrough: Portable Audio Booth for Cochlear Implant...

PRWeb - Pharmaceuticals
Roger D. Kornberg Joins Prize4Life's Scientific Advisory Board

PSGi Publishes Whitepaper about Outsourced Enterprise System Support

Nobledrugstore Offers Free Methotrexate to Help Ease US Shortage...

Audience Response Technology Allows a Fortune 500 Company to Listen to...

Rottenstein Law Group Learns of Research Showing Mom's SSRI Use...

Scientific American
Can Fast Reactors Speedily Solve Plutonium Problems

How to See Around Corners

Something to Chew On: Healthier Hot Dogs Substitute Cellulose for Saturated Fats

"Horizontal Tornado" Captured by Amateur Videographer

Sound Barrier: Can High-Power Ultrasound Protect Produce from Pathogens

Sports - ESPN Basketball
Medcalf: Sweet 16 offers evidence of evolving nature of college big man

Pickeral: Adversity is nothing new to North Carolina

Report: Tarkanian suffered 'mild heart attack'

Vols' Maymon has surgery to repair right knee

Concordia rallies to win 1st NAIA title since '03

Sports News - ESPN
Lewis III follows dad's path, commits to Miami

USC WR Woods (ankle) to miss rest of spring

Army LB Rodriguez receives Sullivan Award

Troubled Georgia tailback Thomas to transfer

Oregon, Mich. St. to begin football series in '14

Xconomy Life Sciences
Verve Raises $7M, Studies Mobile Paradox for Old Media Customers

OVP, Looking for a Home Run, Hits Bunt Single With Complete Genomics

Boston's Deal News: Amazon Acquires Kiva, and Tech IPOs

Ariad and Merck Face Tough FDA Review of Sarcoma Pill

Biotech's New Frontier: Europe

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)